Efficacy of soluble fibre, antispasmodic drugs and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 117-131.
Published: 22nd July 2020
Authors: Black CJ, Yuan Y , Selinger CP, Camilleri CP, Quigley EMM, Moayyedi P et al.
There were 51 RCTs that included 4644 patients. Most studies were short term (up to 12 weeks), and only 13 were at low risk of bias. Peppermint oil was ranked first for global IBS symptoms, and tricyclic antidepressants best for pain.Pubmed Link
You may also be interested in
Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn’s Disease. A Randomized Controlled Trial. Ann Surg 2019; 269: 420-426.
Authors: Uchino M, Ikeuchi H, Bando T, Chohno T, Sasaki H, Horio Y et al.
Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet 2017; 390: 2779-2789.
Authors: Colombel J-F, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T et al.
A mechanistic multicentre, parallel group randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut 2016; 65: 91-99.
Authors: Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y et al.
Authors: Giovanni B, Cremon C, Annese V, Basilisco G, Bazzoli M, et al. et al.
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut 2014; 63: 1617-1625.
Authors: Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G et al. et al.
A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease. Gut 2013; 62: 1288–1294.
Authors: Sands BE, Katz S, Wolf DC, Feagan BG, Wang T, Gustofson LM et al. et al.
HAnd suture versus STApling for closure of loop ileostomy (HASTA Trial): results of a multicenter randomized trial. Ann Surg 2012; 256: 828–836.
Authors: Loffler T, Rossion I, Bruckner T, Diener MK, Koch M, von Frankenberg M et al. et al.
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011; 60: 902–914.
Authors: Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O’Keefe SJ. et al.
Infliximab, azathioprine or combination therapy for Crohn’s Disease. N Engl J Med 2010; 362: 1383-95.
Authors: Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kombluth A, Rachmilewitz D et al. et al.
A sprayable hydrogel adhesion barrier facilitates closure of defunctioning loop ileostomy: a randomized trial. Dis Colon Rectum 2008; 51: 956-960.
Authors: Tjandra JJ, Chan MKY.
Long term outcomes of laparoscopic versus open ileocolic resection for Crohn’s Disease: follow-up of a prospective randomized trial Surgery 2008; 144: 622-628
Authors: Stocchi L, Milsom JW, Fazio VW
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomised, controlled trials Dis Colon Rectum 2008; 51: 1775-1780
Authors: Nikfar S, Rahimi R, Rahimi F, Derakhshani S, Abdollahi M